Details

Notice to Stakeholders - Policy Statement on the Naming of Biologic Drugs - Canada.ca

Metadata and links for an archived snapshot.

Source: Health Canada
Date: Mar 4, 2026 · edition #6
Timestamp: 2026-03-04T00:20:50.195Z
Language: en
Original URL: https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/biosimilar-biologic-notice-to-stakeholders-drugs-naming-of-biologics.html
Replay URL: https://replay.healtharchive.ca/job-6/20260304002050/https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/biosimilar-biologic-notice-to-stakeholders-drugs-naming-of-biologics.html#ha_snapshot=581925
ID: 581925
Status: 200
Type: text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

Other snapshots